User:Mr. Ibrahem/Lincomycin
Clinical data | |
---|---|
Trade names | Lincocin, Biocine, others |
AHFS/Drugs.com | Monograph |
MedlinePlus | a609005 |
Routes of administration | IM/IV |
Drug class | Lincosamide[1] |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | N/A |
Elimination half-life | 5.4 ± 1.0 h after IM or IV administration |
Excretion | renal and biliary |
Identifiers | |
| |
Chemical and physical data | |
Formula | C18H34N2O6S |
Molar mass | 406.54 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Lincomycin, sold under the brand name Lincocin among others, is an antibiotic used to treat staphylococci and streptococci infections.[1] Use is only recommended when other options are not suitable.[1] It is used by injection into a muscle or vein.[1]
Common side effects include nausea, diarrhea, rash, itchiness, muscle pains, ringing in the ears, and world spinning.[1] Other side effects may include allergic reactions, Clostridioides difficile infection, low blood cells, and liver problems.[1] Safety in pregnancy is unclear.[1] It is a lincosamide, which is similar to but less effective than clindamycin.[1]
Lincomycin was approved for medical use in the United States in 1964.[1] In the United States 10 doses of 600 mg costs about 280 USD as of 2021.[2] It is made from Streptomyces lincolnensis.[1]
References[edit]
- ^ a b c d e f g h i j k l "Lincomycin Monograph for Professionals". Drugs.com. Archived from the original on 27 January 2021. Retrieved 23 November 2021.
- ^ "Lincomycin Prices, Coupons & Patient Assistance Programs". Drugs.com. Archived from the original on 16 January 2021. Retrieved 23 November 2021.